Nuveen Real Asset Income and Growth Fund

Nuveen Real Asset Income and Growth Fund is an closed ended balanced mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the public equity markets across the globe. The fund also makes its investments in depository receipts. It invests in stocks of companies operating in real estate sector. For the fixed income portion of its portfolio the fund invest in investment grade quality rated BB+/Ba1 or lower. Nuveen Real Asset Income and Growth Fund was formed on April 25, 2012 and is domiciled in the United States.

Nuveen Real Asset Income and Growth Fund trades as JRI on NYSE. The company is classified in Financial Services / Asset Management - Income and reports in USD.

The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $43.60M of revenue and $49.11M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nuveen Real Asset Income and Growth Fund can be compared against peers such as Wells Fargo Advantage Funds - Allspring Income Opportunities Fund, Cohen & Steers Closed-End Opportunity Fund, Inc., Nuveen Global High Income Fund, Nuveen New York Quality Municipal Income Fund, Virtus Convertible & Income Fund, Nuveen Multi-Asset Income Fund.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $345.85M, beta of 0.90, and return on equity of +13.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

JRI currently shows total debt of $174.13M and beta of 0.90. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-05-28 00:00:00), SC 13G/A (2026-04-30 00:00:00), SC 13G (2026-04-06 00:00:00), 4 (2026-03-18 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nuveen.com/cef/Product/Overview.aspx?fundcode=JRI

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.